Two non-specific melanocortin agonist peptides, bremelanotide and afamelanotide, have been approved for the treatment of hypoactive sexual desire disorder and erythropoietic protoporphyria-associated phototoxicity, respectively, demonstrating the safety of this new drug class
When the effort required by rodents to obtain palatable food was assessed, exendin-4 was found to decrease operant responding on both fixed and progressive ratio schedules, further supporting a reduction in the motivational drive for palatable foods (Bernosky-Smith et al., 2016)
Wegovy is approved for chronic weight management in people with obesity or overweight with weight-related health conditions
Although uncommon, more serious side effects can occur with GLP-1 medications
We dont prevent, treat or cure any diseases
It is not advisable to use other weight loss products while taking orlistat